2575 related articles for article (PubMed ID: 25058905)
1. Cisplatin in cancer therapy: molecular mechanisms of action.
Dasari S; Tchounwou PB
Eur J Pharmacol; 2014 Oct; 740():364-78. PubMed ID: 25058905
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin: The first metal based anticancer drug.
Ghosh S
Bioorg Chem; 2019 Jul; 88():102925. PubMed ID: 31003078
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?
Bowden NA
Cancer Lett; 2014 May; 346(2):163-71. PubMed ID: 24462818
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of platinum compounds.
Hartmann JT; Lipp HP
Expert Opin Pharmacother; 2003 Jun; 4(6):889-901. PubMed ID: 12783586
[TBL] [Abstract][Full Text] [Related]
5. Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted.
Ali R; Aouida M; Alhaj Sulaiman A; Madhusudan S; Ramotar D
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806243
[TBL] [Abstract][Full Text] [Related]
6. [Molecular bases of platinum-resistance in testicular cancer].
Germà-Lluch JR; Piulats JM
Arch Esp Urol; 2013 Jun; 66(5):524-35. PubMed ID: 23793770
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin versus cisplatin in solid tumors: an analysis of the literature.
Lokich J; Anderson N
Ann Oncol; 1998 Jan; 9(1):13-21. PubMed ID: 9541678
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin and platinum drugs at the molecular level. (Review).
Boulikas T; Vougiouka M
Oncol Rep; 2003; 10(6):1663-82. PubMed ID: 14534679
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies.
Ho GY; Woodward N; Coward JI
Crit Rev Oncol Hematol; 2016 Jun; 102():37-46. PubMed ID: 27105947
[TBL] [Abstract][Full Text] [Related]
10. The role of DNA repair pathways in cisplatin resistant lung cancer.
O'Grady S; Finn SP; Cuffe S; Richard DJ; O'Byrne KJ; Barr MP
Cancer Treat Rev; 2014 Dec; 40(10):1161-70. PubMed ID: 25458603
[TBL] [Abstract][Full Text] [Related]
11. Platinum anticancer drugs. From serendipity to rational design.
Monneret C
Ann Pharm Fr; 2011 Nov; 69(6):286-95. PubMed ID: 22115131
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy.
Makovec T
Radiol Oncol; 2019 Mar; 53(2):148-158. PubMed ID: 30956230
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of platinum-drug cytotoxicity in a human head and neck squamous cell carcinoma line and its platinum-resistant variant by liposomal amphotericin B and phospholipase A2-II.
Ferguson PJ; Currie C; Vincent MD
Drug Metab Dispos; 1999 Dec; 27(12):1399-405. PubMed ID: 10570020
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-based combination therapy for cancer.
Minerva ; Bhat A; Verma S; Chander G; Jamwal RS; Sharma B; Bhat A; Katyal T; Kumar R; Shah R
J Cancer Res Ther; 2023; 19(3):530-536. PubMed ID: 37470570
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin in cancer treatment.
Romani AMP
Biochem Pharmacol; 2022 Dec; 206():115323. PubMed ID: 36368406
[TBL] [Abstract][Full Text] [Related]
16. A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress.
Bruno PM; Liu Y; Park GY; Murai J; Koch CE; Eisen TJ; Pritchard JR; Pommier Y; Lippard SJ; Hemann MT
Nat Med; 2017 Apr; 23(4):461-471. PubMed ID: 28263311
[TBL] [Abstract][Full Text] [Related]
17. Will the Interactions of Some Platinum (II)-Based Drugs with B-Vitamins Reduce Their Therapeutic Effect in Cancer Patients? Comparison of Chemotherapeutic Agents such as Cisplatin, Carboplatin and Oxaliplatin-A Review.
Szefler B; Czeleń P
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675064
[TBL] [Abstract][Full Text] [Related]
18. Superior cytotoxicity and DNA cross-link induction by oxaliplatin versus cisplatin at lower cellular uptake in colorectal cancer cell lines.
Virag P; Perde-Schrepler M; Fischer-Fodor E; Tatomir C; Dorneanu SA; Cernea VI; Irimie A
Anticancer Drugs; 2012 Nov; 23(10):1032-8. PubMed ID: 22614106
[TBL] [Abstract][Full Text] [Related]
19. Interactions of cisplatin with non-DNA targets and their influence on anticancer activity and drug toxicity: the complex world of the platinum complex.
Mezencev R
Curr Cancer Drug Targets; 2015; 14(9):794-816. PubMed ID: 25431081
[TBL] [Abstract][Full Text] [Related]
20. Unexpected therapeutic effects of cisplatin.
Raudenska M; Balvan J; Fojtu M; Gumulec J; Masarik M
Metallomics; 2019 Jul; 11(7):1182-1199. PubMed ID: 31098602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
